fda glp-1 warning news november 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes GLP-1 Receptor Agonists and vision

It remains under investigation in clinical trials registered on ClinicalTrials.gov and the EU Clinical Trials Register, and is not licensed for prescription or self-administration outside of formally approved research settings

Severe gastrointestinal side effects reported by users of GLP 1 receptor agonist drugs have resulted in the organization of a mass tort lawsuit, with patients seeking compensation for medical expenses and other damages

Higgins V, Asgari S, Hamilton JK, Wolska A, Remaley AT, Hartmann B, et al

If you are struggling to get your insurance to cover Wegovy, you can: Appeal to get the insurance company to change its decision

Protein is an essential nutrient that many people prioritize in their GLP-1 diet